Table 1.
Clinical characteristics of COVID 19 patients according to their Chlamydia and Mycoplasma serology status.
| Chlamydia and Mycoplasma serology status |
P value | ||
| Positive (n = 242) | Negative (n = 201) | ||
| Age, mean (IQR) | 71 (19) | 68 (20) | 0.11 |
| Age group, n°/total (%) | |||
| 0–20 | 0 | 1 (0.4) | / |
| 21–40 | 5 (2) | 9 (4.4) | 0.2 |
| 41–60 | 58 (23.9) | 51 (25.3) | 0.8 |
| 61–80 | 127 (52.4) | 100 (49.7) | 0.6 |
| >80 | 52 (21.4) | 40 (19.9) | 0.7 |
| Gender, n°/total (%) | |||
| Male | 173 (71.4) | 121 (60.1) | 0.01 |
| Number of comorbidities, n (%) | |||
| None | 50 (20.6) | 54 (26.8) | 0.15 |
| 1 or 2 | 99 (40.9) | 89 (44.2) | 0.53 |
| ≥3 | 93 (38.4) | 58 (28.8) | 0.04 |
| Comorbidities | |||
| Diabetes | 49 (20.2) | 34 (16.9) | 0.4 |
| Hypertension | 130 (53.7) | 94 (46.7) | 0.15 |
| Cardiovascular disease | 69 (28.5) | 42 (20.8) | 0.08 |
| Chronic pulmonary disease | 17 (7) | 18 (8.9) | 0.5 |
| Chronic kidney disease | 13 (5.3) | 3 (1.4) | 0.03 |
| Hyperlipidemia | 25 (10.3) | 7 (3.4) | 0.005 |
| Malignancy | 18 (7) | 16 (7.9) | 0.87 |
| Hematologic disease | 8 (3.3) | 8 (3.4) | 0.9 |
| Neurologic disease | 11 (4.5) | 5 (2.4) | 0.3 |
| Symptoms, n (%) | |||
| Fever (temperature >37.5 °C) | 174 (71.9) | 164 (81.5) | 0.02 |
| Cough | 127 (52.4) | 96 (47.7) | 0.37 |
| Dyspnea | 116 (47.9) | 70 (34.8) | 0.005 |
| Chest pain | 4 (1.6) | 3 (1.4) | 0.80 |
| Nausea | 2 (0.82) | 3(1.4) | 0.83 |
| Vomiting | 13 (5.3) | 11 (5.4) | 0.86 |
| Diarrhea | 19 (7.8) | 21 (10.4) | 0.43 |
| Myalgia | 15 (6.1) | 10 (4.9) | 0.72 |
| Loss of smell and taste | 2 (0.82) | 0 | / |